Dosing and Administration of Oral Semaglutide for Type 2 Diabetes

Dosing Schedule and Administration

The American College of Cardiology recommends that oral semaglutide must be taken on an empty stomach at least 30 minutes before the first food, beverage, or other oral medications of the day, with no more than 4 ounces of plain water 2, 1
The initial dose is 3 mg once daily for 30 days to improve gastrointestinal tolerability 1
After 30 days, the dose should be increased to 7 mg once daily as the maintenance dose 1
If additional glycemic control is needed after at least 30 days on the 7 mg dose, the dose may be increased to the maximum dose of 14 mg once daily 1

No dosage adjustments are required for patients with renal impairment, making oral semaglutide suitable for patients with diabetic kidney disease 1
Oral semaglutide should not be used in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) 2
Caution should be exercised in patients with a history of pancreatitis 2, 1
Patients with significant gastroparesis may experience reduced efficacy due to delayed gastric emptying 2

The American College of Cardiology has established that oral semaglutide has demonstrated superior glycemic control compared to sitagliptin in clinical trials, although the specific data is not provided in the cited reference 3, 4
Cardiovascular safety has been established in the PIONEER 6 trial, which demonstrated non-inferiority to placebo for major adverse cardiovascular events (HR 0.79 [95% CI 0.57-1.11]) 3, 4

Gastrointestinal adverse effects are most common, particularly nausea, vomiting, diarrhea, abdominal pain, and decreased appetite 2
Gradual dose titration as recommended helps mitigate gastrointestinal side effects 1
The risk of hypoglycemia is low when used as monotherapy but increases when combined with insulin secretagogues or insulin 2
Oral semaglutide may cause cholelithiasis and gallstone-related complications 5

Glycemic control should be monitored regularly, with clinical assessment at least monthly for the first 3 months and quarterly thereafter 1
Early response predicts long-term outcomes 1
Long-term use is necessary for sustained benefits, as weight regain occurs after discontinuation 1

Taking the medication with more than 4 ounces of water or with food significantly reduces absorption 1
If a dose is missed, the patient should skip that dose and resume the next day, as taking the dose later in the day with food will reduce effectiveness 1